避妊（バースコントロール）は、排卵、受精、および着床の正常なプロセスを妨げることにより、妊娠を防ぎます。インプラントや注射、子宮内避妊器具 (IUD)、ピルや膣リング、バリア法、滅菌、自然療法など、多くの避妊法があります。避妊は一般に、精子が卵子に到達して受精するのを防ぐ（バリア法とIUD法）、卵子が毎月放出されるのを防ぐ（ホルモン）、生殖機能をブロックする（不妊化）、受精卵が子宮に着床するのを防ぐ（ホルモン）ことによって機能します。
目次
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Female Contraception - Overview
Female Contraception - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Female Contraception - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Female Contraception - Companies Involved in Therapeutics Development
Female Contraception - Drug Profiles
Female Contraception - Dormant Projects
Female Contraception - Discontinued Products
Female Contraception - Product Development Milestones
Featured News & Press Releases
Oct 26, 2022: Phexxi mechanism of action article published in the Journal of Therapeutic Advances in Reproductive Health
Oct 24, 2022: Mithra and Fuji announce approval of NEXTSTELLIS in Thailand
Oct 06, 2022: Evofem Biosciences announces approval of Phexxi in Nigeria
Sep 21, 2022: Mithra and Lotus announce approval of ALYSSA, an innovative oral contraceptive, in both Taiwan and Hong Kong
Sep 19, 2022: Inventor of the year awarded to developer of Phexxi
Sep 16, 2022: Large Commercial payer adds Phexxi to formulary for standard plans nationwide
Aug 02, 2022: Nextstellis oral contraceptive has been nominated for the 2022 Prix Galien USA award for best pharmaceutical agent
Aug 01, 2022: Mithra Announces Mayne Pharma's New Direct-to-Consumer Campaign to Further Increase Awareness of NEXTSTELLIS in the U.S.
Jul 29, 2022: Mayne Pharma and GoodRx announce new initiative to increase awareness of NEXTSTELLIS and expand access to birth control
Jul 26, 2022: NEXTSTELLIS oral contraceptive now available in Australia
Jul 26, 2022: Evofem's House Rules Campaign featuring Annie Murphy receives Significant Industry Recognition
Jun 30, 2022: Evofem strengthens Phexxi intellectual property with new composition of matter patent from USPTO
Jun 16, 2022: Phexxi prevented 99% of pregnancies per act of intercourse in a post hoc analysis of phase 3 AMPOWER Clinical Trial Data
May 10, 2022: Evofem Biosciences to decrease cost of goods 45 percent through new partnership with Bora Pharmaceutical Services for the commercial manufacturing of Phexxi
Apr 19, 2022: Journal of Sexual Medicine Publishes Sexual Satisfaction Data Involving Phexxi from Evofem's Phase 3 AMPOWER Clinical Trial
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Number of Products under Development for Female Contraception, 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Companies, 2022 (Contd..1)
Number of Products under Development by Universities/Institutes, 2022
Products under Development by Companies, 2022
Products under Development by Companies, 2022 (Contd..1)
Products under Development by Companies, 2022 (Contd..2)
Products under Development by Universities/Institutes, 2022
Number of Products by Stage and Target, 2022
Number of Products by Stage and Mechanism of Action, 2022
Number of Products by Stage and Route of Administration, 2022
Number of Products by Stage and Molecule Type, 2022
Female Contraception - Dormant Projects, 2022
Female Contraception - Dormant Projects, 2022 (Contd..1)
Female Contraception - Discontinued Products, 2022
List of Figures
Number of Products under Development for Female Contraception, 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Number of Products by Top 10 Targets, 2022
Number of Products by Stage and Top 10 Targets, 2022
Number of Products by Top 10 Mechanism of Actions, 2022
Number of Products by Stage and Top 10 Mechanism of Actions, 2022
Number of Products by Top 10 Routes of Administration, 2022
Number of Products by Stage and Top 10 Routes of Administration, 2022
Number of Products by Top 10 Molecule Types, 2022
Number of Products by Stage and Top 10 Molecule Types, 2022
